Taegyun Kim, M.D., Ph.D.

During his dermatology residency and clinical fellowship training, Dr. Kim investigated the immunophenotype of pathogenic dendritic cell subsets in psoriatic inflammation (J Invest Dermatol, 2014; J Invest Dermatol, 2018). During his M.D-Ph.D. training, he found that the epigenetic molecule CCCTC-binding factor controls the maintenance of self-perpetuating immune cell populations, such as epidermal Langerhans cells and hematopoietic stem cells (J Allergy Clin Immunol, 2015; Exp Mol Med, 2017).

Dr. Kim's current research focuses on basic and translational questions obtained from clinical practice to understand the pathogenic immune circuit and memory that drive the chronic recurrent features of inflammatory skin disorders. These disorders include psoriasis, recalcitrant eczema, and autoimmune rheumatic skin diseases in the context of cellular communication (J Allergy Clin Immunol, 2023; EBioMedicine, 2024; Cell Rep, 2024). Furthermore, he seeks to understand how the skin immune microenvironment communicates as a network within the skin about the close interaction with the outside world, such as the microbiome (Cell Host Microbe, 2024).